Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 933 to 982 of 6456 in total
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
467\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylate cyclase, type v (ec 4.6.1.1) (atp pyrophosphate-lyase) (adenylyl cyclase) (fragment). [source:swissprot;acc:o95622]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
248.152\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.226\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07686\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 31 isoform 1; dead/dexh helicase ddx31. [source:refseq;acc:nm\_022779]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
248.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.579\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.981\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
468\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 7.6 kda polypeptide (ec 2.7.7.6) (rpb10) (rpb7.6) (rpabc5). [source:swissprot;acc:p52436]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
237.627\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
253.604\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.977\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
leucine-rich repeat-containing protein 15 precursor (hlib). [source:swissprot;acc:q8tf66]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
248.152\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
267.226\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07686\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
469\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fem-1 homolog b; fem-1-like death receptor binding protein; fem-1 (c.elegans) homolog b. [source:refseq;acc:nm\_015322]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 2 (potassium channel kv1.2) (rbk2) (hbk5) (ngk1) (mk2) (hukiv). [source:swissprot;acc:p16389]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.789\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.818\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.971\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
470\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
inhibitor of growth family, member 1; inhibitor of growth 1. [source:refseq;acc:nm\_005537]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
224.535\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
240.476\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.941\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
leucine-rich repeat protein lrrc3 precursor. [source:swissprot;acc:q9by71]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
248.152\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
267.226\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07686\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
471\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
laminin gamma-1 chain precursor (laminin b2 chain). [source:swissprot;acc:p11047]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger-like protein 9. [source:refseq;acc:nm\_033414]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
250.942\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
235.004\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
15.938\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
472\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
membrane-associated transporter protein (aim-1 protein) (melanoma antigen aim1). [source:swissprot;acc:q9umx9]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thymic stromal co-transporter. [source:refseq;acc:nm\_033051]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
248.152\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.226\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07686\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
473\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein-like 1 (gtp-binding protein hsr1). [source:swissprot;acc:p36915]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
250.942\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.004\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.938\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pre-mrna processing factor 31 homolog; pre-mrna processing factor 31 homolog (yeast). [source:refseq;acc:nm\_015629]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.661\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.651\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07637\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
474\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 1 (potassium channel kv1.1) (huki) (hbk1). [source:swissprot;acc:q09470]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.727\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.816\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.911\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 2 (potassium channel kv1.2) (rbk2) (hbk5) (ngk1) (mk2) (hukiv). [source:swissprot;acc:p16389]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.789\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.818\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07576\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
475\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 1 (potassium channel kv1.1) (huki) (hbk1). [source:swissprot;acc:q09470]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
226.727\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.816\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07547\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein cgi-27 (c21orf19-like protein). [source:swissprot;acc:q9y316]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
236.964\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
252.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.896\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
476\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 4 (potassium channel kv1.4) (hk1) (hpcn2) (hbk4) (hukii). [source:swissprot;acc:p22459]\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
226.681\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
210.814\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07527\vspace{3pt}}\\\cline{3-3}\cline{6-6}
&&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
15.867\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
477\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 7 (pak-interacting exchange factor beta) (beta-pix) (cool-1) (p85). [source:swissprot;acc:q14155]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
220.183\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.015\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.832\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
saccharomyces cerevisiae nip7p homolog. [source:refseq;acc:nm\_016101]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.926\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.547\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0741\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
478\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 2 (ec 2.7.1.-) (p21-activated kinase 2) (pak-2) (pak65) (gamma-pak) (s6/h4 kinase). [source:swissprot;acc:q13177]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.979\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.808\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor iiib 90 kda subunit (tfiiib90) (htfiiib90) (b- related factor 1) (hbrf) (tata box-binding protein-associated factor, rna polymerase iii, subunit 2) (taf3b2). [source:swissprot;acc:q92994]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.051\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.321\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07409\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
479\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
conserved oligomeric golgi complex subunit 5 (13s golgi transport complex 90 kda subunit) (gtc-90) (golgi transport complex 1). [source:swissprot;acc:q9up83]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.172\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.808\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein family a, member 1; gar1 protein. [source:refseq;acc:nm\_018983]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.051\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.321\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07409\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
480\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuropilin- and tolloid-like protein 2 precursor. [source:refseq;acc:nm\_018092]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
237.109\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
254.667\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07405\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 1 (ec 2.7.1.-) (p21-activated kinase 1) (pak-1) (p65-pak) (alpha-pak). [source:swissprot;acc:q13153]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.172\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.808\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
481\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuropilin- and tolloid-like protein 1 isoform 3 precursor. [source:refseq;acc:nm\_138966]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
237.109\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
254.667\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07405\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 3 (ec 2.7.1.-) (p21-activated kinase 3) (pak-3) (beta-pak) (oligophrenin-3). [source:swissprot;acc:o75914]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.979\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.808\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
482\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogenous nuclear ribonucleoprotein u (hnrnp u) (scaffold attachment factor a) (saf-a). [source:swissprot;acc:q00839]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
237.109\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
254.667\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07405\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 6 (pak-interacting exchange factor alpha) (alpha-pix) (cool-2). [source:swissprot;acc:q15052]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.161\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.789\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
483\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
runt-related transcription factor 2 (core-binding factor, alpha 1 subunit) (cbf-alpha 1) (acute myeloid leukemia 3 protein) (oncogene aml-3) (polyomavirus enhancer binding protein 2 alpha a subunit) (pebp2-alpha a) (pea2-alpha a) (sl3-3 enhancer factor 1 alpha a subunit) (sl3/akv core-binding factor alpha a subunit) (osteoblast- specific transcription factor 2) (osf-2). [source:swissprot;acc:q13950]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
237.109\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
254.667\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07405\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor iiib 90 kda subunit (tfiiib90) (htfiiib90) (b- related factor 1) (hbrf) (tata box-binding protein-associated factor, rna polymerase iii, subunit 2) (taf3b2). [source:swissprot;acc:q92994]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.051\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.321\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.73\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
484\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
e1b-55kda-associated protein 5 isoform a. [source:refseq;acc:nm\_007040]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
237.109\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
254.667\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07405\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein family a, member 1; gar1 protein. [source:refseq;acc:nm\_018983]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.051\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.321\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.73\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
485\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l18. [source:swissprot;acc:q07020]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
237.109\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
254.667\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07405\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 2c beta isoform (ec 3.1.3.16) (pp2c-beta). [source:swissprot;acc:o75688]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.276\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.627\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.649\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
486\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 6 (eif-6) (b4 integrin interactor) (cab) (p27(bbp)) (b(2)gcn homolog). [source:swissprot;acc:p56537]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
248.866\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
233.287\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.579\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mct-1 protein. [source:refseq;acc:nm\_014060]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.313\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
243.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07387\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
487\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
malate dehydrogenase, mitochondrial precursor (ec 1.1.1.37). [source:swissprot;acc:p40926]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
238.529\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
254.099\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.57\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l22. [source:refseq;acc:nm\_014180]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.313\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
243.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07387\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
488\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gaba-a receptor-associated protein. [source:sptrembl;acc:q9by60]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
82.5916\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
98.0548\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.4632\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
squamous cell carcinoma antigen recognized by t cells 1; u4/u6.u5 tri-snrnp-associated 110 kda protein; ige autoantigen; sart1(259) protein; sart1(800) protein. [source:refseq;acc:nm\_005146]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.026\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.798\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07258\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
489\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apg3p; pc3-96 protein. [source:refseq;acc:nm\_022488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
82.5916\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
98.0548\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.4632\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 2c beta isoform (ec 3.1.3.16) (pp2c-beta). [source:swissprot;acc:o75688]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.276\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.627\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07257\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
490\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lupus la protein (sjogren syndrome type b antigen) (ss-b) (la ribonucleoprotein) (la autoantigen). [source:swissprot;acc:p05455]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
242.531\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
227.136\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.395\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 7 (pak-interacting exchange factor beta) (beta-pix) (cool-1) (p85). [source:swissprot;acc:q14155]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.183\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.015\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0719\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
491\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
metalloprotease 1; metalloprotease 1 (pitrilysin family). [source:refseq;acc:nm\_014889]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
150.959\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
166.351\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15.392\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar gtp-binding protein 1 (chronic renal failure gene protein) (gtp-binding protein ngb). [source:swissprot;acc:q9bze4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.951\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07184\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/